Skip to main content

Table 1 Demographics and clinical information of patients (n = 51)

From: Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study

Characteristics

 

n (%)

Age (years, mean ± SD)

 

52.6 ± 9.5

Race

Chinese

40 (78.4)

Malay

4 (7.8)

Indian

6 (11.8)

Other

1 (2.0)

Marital status

Single

8 (15.7)

Married

40 (78.4)

Divorced

3 (5.9)

Education level

None

1 (2.0)

Primary school

6 (11.8)

Secondary school

22 (43.1)

Pre-university

7 (13.7)

Graduate/postgraduate

15 (29.4)

Occupation

Currently working

36 (70.6)

Currently not working

13 (25.4)

Retired

1 (2.0)

Long-term medical leave

1 (2.0)

Cancer diagnosis

Stage I

7 (13.7)

Stage II

32 (62.8)

Stage III

12 (23.5)

ECOG Performance status

0

51 (100.0)

Menopausal status

Pre-menopausal

20 (39.2)

Post-menopausal

31 (60.8)

Chemotherapy regimen

Anthracycline-based

29 (56.9)

Taxane-based

22 (43.1)

Behavioral symptoms, median (IQR)

 Baseline fatigue (BFI total score, out of 10)

0.7 (0.1,1.8)

 Baseline anxiety (BAI total score, out of 63)

0.0 (0.0,0.0)

 Baseline depression (BDI total score, out of 63)

3.0 (1.0,8.0)

  1. Abbreviations: SD standard deviation, IQR interquartile range, ECOG Eastern Cooperative Oncology Group, BFI Brief Fatigue Inventory, BAI Beck Anxiety Inventory, BDI Beck Depression Inventory